Glucocorticoids and the prenatal programming of neurodevelopmental disorders

Current Opinion in Behavioral Sciences

Volumn 7, Issue , 2016, Pages 1-7

  Cartier, Jessy ^a   Zeng, Yan ^a   Drake, Amanda J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; NEUROTRANSMITTER;

BEHAVIOR; BRAIN DEVELOPMENT; DEVELOPMENTAL DISORDER; EMBRYO; EPIGENETICS; GENE CONTROL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MATERNAL STRESS; NEURODEVELOPMENTAL DISORDER; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; NUCLEAR REPROGRAMMING; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; REVIEW;

EID: 84939839543     PISSN: None     EISSN: 23521546     Source Type: Journal    
DOI: 10.1016/j.cobeha.2015.08.001     Document Type: Review

References (55)

1. Barker D.J., Osmond C., Law C.M. The intrauterine and early postnatal origins of cardiovascular disease and chronic bronchitis. J Epidemiol Community Health 1989, 43:237-240.
2. Seckl J.R., Holmes M.C. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal programming of adult pathophysiology. Nat Clin Pract Endocrinol Metab 2007, 3:479-488.
3. Gluckman P., Hanson M. Echoes of the past: evolution, development, health and disease. Discov Med 2004, 4:401-407.
4. Spratt E.G., Nicholas J.S., Brady K.T., Carpenter L.A., Hatcher C.R., Meekins K.A., Furlanetto R.W., Charles J.M. Enhanced cortisol response to stress in children in autism. J Autism Dev Disord 2012, 42:75-81.
5. Bradley A.J., Dinan T.G. A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality. J Psychopharmacol 2010, 24:91-118.
6. Seckl J.R. 11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?. Front Neuroendocrinol 1997, 18:49-99.
7. Buitelaar J.K., Huizink A.C., Mulder E.J., de Medina P.G.R., Visser G.H.A. Prenatal stress and cognitive development and temperament in infants. Neurobiol Aging 2003, 24(Suppl. 1):S53-S60. discussion S67-8.
8. Antenatal corticosteroids revisited: repeat courses-National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000. Obstet Gynecol 2001, 98:144-150.
9. Speiser P.W., Azziz R., Baskin L.S., Ghizzoni L., Hensle T.W., Merke D.P., Meyer-Bahlburg H.F.L., Miller W.L., Montori V.M., Oberfield S.E., et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010, 95:4133-4160.
10. French N.P., Hagan R., Evans S.F., Mullan A., Newnham J.P. Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol 2004, 190:588-595.
11. Alexander N., Rosenlöcher F., Stalder T., Linke J., Distler W., Morgner J., Kirschbaum C. Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children. J Clin Endocrinol Metab 2012, 97:3538-3544.
12. Khalife N., Glover V., Taanila A., Ebeling H., Järvelin M-R., Rodriguez A. Prenatal glucocorticoid treatment and later mental health in children and adolescents. PLoS One 2013, 8:e81394.
13. Hirvikoski T., Nordenström A., Lindholm T., Lindblad F., Ritzén E.M., Lajic S. Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems?. Eur J Endocrinol 2008, 159:309-316.
14. Hauser J., Knapman A., Zürcher N.R., Pilloud S., Maier C., Diaz-Heijtz R., Forssberg H., Dettling A., Feldon J., Pryce C.R. Effects of prenatal dexamethasone treatment on physical growth, pituitary-adrenal hormones, and performance of motor, motivational, and cognitive tasks in juvenile and adolescent common marmoset monkeys. Endocrinology 2008, 149:6343-6355.
15. Hougaard K.S., Andersen M.B., Kjaer S.L., Hansen A.M., Werge T., Lund S.P. Prenatal stress may increase vulnerability to life events: comparison with the effects of prenatal dexamethasone. Brain Res Dev Brain Res 2005, 159:55-63.
16. Oliveira M., Bessa J.M., Mesquita A., Tavares H., Carvalho A., Silva R., Pêgo J.M., Cerqueira J.J., Palha J.A., Almeida O.F.X., et al. Induction of a hyperanxious state by antenatal dexamethasone: a case for less detrimental natural corticosteroids. Biol Psychiatry 2006, 59:844-852.
17. Oliveira M., Rodrigues A-J., Leão P., Cardona D., Pêgo J.M., Sousa N. The bed nucleus of stria terminalis and the amygdala as targets of antenatal glucocorticoids: implications for fear and anxiety responses. Psychopharmacology (Berl) 2012, 220:443-453.
18. Nagano M., Ozawa H., Suzuki H. Prenatal dexamethasone exposure affects anxiety-like behaviour and neuroendocrine systems in an age-dependent manner. Neurosci Res 2008, 60:364-371.
19. Neigh G.N., Owens M.J., Taylor W.R., Nemeroff C.B. Changes in the vascular area fraction of the hippocampus and amygdala are induced by prenatal dexamethasone and/or adult stress. J Cereb Blood Flow Metab 2010, 30:1100-1104.
20. Zeng Y., Brydges N.M., Wood E.R., Drake A.J., Hall J. Prenatal glucocorticoid exposure in rats: programming effects on stress reactivity and cognition in adult offspring. Stress 2015, in press.
21. Diaz R., Brown R.W., Seckl J.R. Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions. J Neurosci 1998, 18:2570-2580.
22. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joëls M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998, 19:269-301.
23. Meaney M.J., Aitken D.H. The effects of early postnatal handling on hippocampal glucocorticoid receptor concentrations: temporal parameters. Brain Res 1985, 354:301-304.
24. Zuloaga D.G., Carbone D.L., Handa R.J. Prenatal dexamethasone selectively decreases calretinin expression in the adult female lateral amygdala. Neurosci Lett 2012, 521:109-114.
25. Tijsseling D., Wijnberger L.D.E., Derks J.B., van Velthoven C.T.J., de Vries W.B., van Bel F., Nikkels P.G.J., Visser G.H.A. Effects of antenatal glucocorticoid therapy on hippocampal histology of preterm infants. PLoS One 2012, 7:e33369.
26. Cerqueira J.J., Pêgo J.M., Taipa R., Bessa J.M., Almeida O.F.X., Sousa N. Morphological correlates of corticosteroid-induced changes in prefrontal cortex-dependent behaviors. J Neurosci 2005, 25:7792-7800.
27. Zuloaga D.G., Carbone D.L., Hiroi R., Chong D.L., Handa R.J. Dexamethasone induces apoptosis in the developing rat amygdala in an age-, region-, and sex-specific manner. Neuroscience 2011, 199:535-547.
28. Noorlander C.W., Tijsseling D., Hessel E.V.S., de Vries W.B., Derks J.B., Visser G.H.A., de Graan P.N.E. Antenatal glucocorticoid treatment affects hippocampal development in mice. PLoS One 2014, 9:e85671.
29. Haynes L.E., Griffiths M.R., Hyde R.E., Barber D.J., Mitchell I.J. Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: implications for mood disorders. Neuroscience 2001, 104:57-69.
30. Sze C.-I., Lin Y.-C., Lin Y.-J., Hsieh T.-H., Kuo Y.M., Lin C.-H. The role of glucocorticoid receptors in dexamethasone-induced apoptosis of neuroprogenitor cells in the hippocampus of rat pups. Mediators Inflamm 2013, 2013:628094.
31. Frahm K.A., Tobet S.A. Development of the blood-brain barrier within the paraventricular nucleus of the hypothalamus: influence of fetal glucocorticoid excess. Brain Struct Funct 2014, 10.1007/s00429-014-0787-8.
32. Leão P., Sousa J.C., Oliveira M., Silva R., Almeida O.F.X., Sousa N. Programming effects of antenatal dexamethasone in the developing mesolimbic pathways. Synapse 2007, 61:40-49.
33. Van Etten M.L., Neumark Y.D., Anthony J.C. Male-female differences in the earliest stages of drug involvement. Addiction 1999, 94:1413-1419.
34. Diaz Heijtz R., Fuchs E., Feldon J., Pryce C.R., Forssberg H. Effects of antenatal dexamethasone treatment on glucocorticoid receptor and calcyon gene expression in the prefrontal cortex of neonatal and adult common marmoset monkeys. Behav Brain Funct 2010, 6:18.
35. Welberg L.A., Seckl J.R., Holmes M.C. Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience 2001, 104:71-79.
36. Dunn E., Kapoor A., Leen J., Matthews S.G. Prenatal synthetic glucocorticoid exposure alters hypothalamic-pituitary-adrenal regulation and pregnancy outcomes in mature female guinea pigs. J Physiol 2010, 588:887-899.
37. Shoener J.A., Baig R., Page K.C. Prenatal exposure to dexamethasone alters hippocampal drive on hypothalamic-pituitary-adrenal axis activity in adult male rats. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1366-R1373.
38. Wilcoxon J.S., Redei E.E. Maternal glucocorticoid deficit affects hypothalamic-pituitary-adrenal function and behavior of rat offspring. Horm Behav 2007, 51:321-327.
39. Kunugi H., Hori H., Adachi N., Numakawa T. Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression. Psychiatry Clin Neurosci 2010, 64:447-459.
40. Slotkin T.A., Kreider M.L., Tate C.A., Seidler F.J. Critical prenatal and postnatal periods for persistent effects of dexamethasone on serotonergic and dopaminergic systems. Neuropsychopharmacology 2006, 31:904-911.
41. Nagano M., Liu M., Inagaki H., Kawada T., Suzuki H. Early intervention with fluoxetine reverses abnormalities in the serotonergic system and behavior of rats exposed prenatally to dexamethasone. Neuropharmacology 2012, 63:292-300.
42. Borges S., Coimbra B., Soares-Cunha C., Miguel Pêgo J., Sousa N., João Rodrigues A. Dopaminergic modulation of affective and social deficits induced by prenatal glucocorticoid exposure. Neuropsychopharmacology 2013, 38:2068-2079.
43. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007, 8:253-262.
44. Bredy T.W., Sun Y.E., Kobor M.S. How the epigenome contributes to the development of psychiatric disorders. Dev Psychobiol 2010, 52:331-342.
45. Murgatroyd C., Spengler D. Genetic variation in the epigenetic machinery and mental health. Curr Psychiatry Rep 2012, 14:138-149.
46. Rose C.M., van den Driesche S., Sharpe R.M., Meehan R.R., Drake A.J. Dynamic changes in DNA modification states during late gestation male germ line development in the rat. Epigenetics Chromatin 2014, 7:19.
47. Numata S., Ye T., Hyde T.M., Guitart-Navarro X., Tao R., Wininger M., Colantuoni C., Weinberger D.R., Kleinman J.E., Lipska B.K. DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet 2012, 90:260-272.
48. Palacios-García I., Lara-Vásquez A., Montiel J.F., Díaz-Véliz G.F., Sepúlveda H., Utreras E., Montecino M., González-Billault C., Aboitiz F. Prenatal stress down-regulates Reelin expression by methylation of its promoter and induces adult behavioral impairments in rats. PLoS One 2015, 10:e0117680.
49. Lui C.-C., Hsu M.-H., Kuo H.-C., Chen C.-C., Sheen J.-M., Yu H.-R., Tiao M.-M., Tain Y.-L., Chang K.-A., Huang L.-T. Effects of melatonin on prenatal dexamethasone-induced epigenetic alterations in hippocampal morphology and reelin glutamic Acid decarboxylase 67 S levels. Dev Neurosci 2015, 37:105-114.
50. Matrisciano F., Tueting P., Dalal I., Kadriu B., Grayson D.R., Davis J.M., Nicoletti F., Guidotti A. Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice. Neuropharmacology 2013, 68:184-194.
51. Crudo A., Suderman M., Moisiadis V.G., Petropoulos S., Kostaki A., Hallett M., Szyf M., Matthews S.G. Glucocorticoid programming of the fetal male hippocampal epigenome. Endocrinology 2013, 154:1168-1180.
52. Crudo A., Petropoulos S., Suderman M., Moisiadis V.G., Kostaki A., Hallett M., Szyf M., Matthews S.G. Effects of antenatal synthetic glucocorticoid on glucocorticoid receptor binding, DNA methylation, and genome-wide mRNA levels in the fetal male hippocampus. Endocrinology 2013, 154:4170-4181.
53. Tibu F., Hill J., Sharp H., Marshall K., Glover V., Pickles A. Evidence for sex differences in fetal programming of physiological stress reactivity in infancy. Dev Psychopathol 2014, 26:879-888.
54. Sorge R.E., Martin L.J., Isbester K.A., Sotocinal S.G., Rosen S., Tuttle A.H., Wieskopf J.S., Acland E.L., Dokova A., Kadoura B., et al. Olfactory exposure to males, including men, causes stress and related analgesia in rodents. Nat Methods 2014, 11:629-632.
55. Edge M.D., Ramel W., Drabant E.M., Kuo J.R., Parker K.J., Gross J.J. For better or worse? Stress inoculation effects for implicit but not explicit anxiety. Depress Anxiety 2009, 26:831-837.